Germany · Investor

Leaps by Bayer

Last cheque observed Oct 2026; 8 cheques on record.

Deploying nowCorporate VC

SeedSeries AAgricultureAgtechBiotechnology

Deploying now
100%of best year2cheques in 12 months, 8 on record
Since the last cheque6days00hrs00min00sec
Median round$105MRounds led2 of 8Mostly inUnited States, 100%
Pitch Leaps by Bayer

Leaps by Bayer highlights

  1. 01

    2 cheques in the last 12 months

  2. 02

    Mostly Series B and Series A: 100% of its rounds

  3. 03

    Led 2 rounds

What they do

Type
Corporate VC (from a list, unverified)
Cheque size
Not stated
Stages
SeedSeries A
Sectors
AgricultureAgtechBiotechnology
Based in
Berlin, Germany
Cold pitches
Not stated

The record

Every round we can evidence, newest first8 appearances

  1. 2026

    2 rounds

  2. Oct
    Soufflé TherapeuticsSeries B · US · Google News search$135MWith 16 others
  3. Sept
    RobigoSeries A · US · AgFunderNewsUndisclosedLed
  4. 2024

    2 rounds

  5. Mar
    Capstan TherapeuticsSeries B · US · Firms' own news pages$175MWith 15 others
  6. Feb
    9amHealthSeries A · US · Cigna Ventures$9.5MWith 6 others
  7. 2021

    1 round

  8. Jan
    Senti BiosciencesSeries B · US · Firms' own news pages$105MLed
  9. 2019

    3 rounds

  10. Nov
    eGenesisSeries B · US · FinSMEs$100MWith 6 others
  11. Jul
    Century TherapeuticsUS · FinSMEs$250MWith 2 others
  12. Jan
    Dewpoint TherapeuticsSeries A · US · FinSMEs$60MWith 4 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 4 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Who they invest alongside

The investors most often in the same rounds as Leaps by Bayer. A count of rooms they were both in, not a relationship either has claimed.

ARCH Venture PartnersVC firm2rounds togetherAlexandria Real Estate EquitiesVC firm2rounds togetherPolaris PartnersVC firm2rounds togetherVida VenturesVC firm2rounds together

Recently backed

The latest companies Leaps by Bayer put money into.

RobigoSept 20269amHealth$9.5M · Feb 2024Senti Biosciences$105M · Jan 2021Century Therapeutics$250M · Jul 2019Dewpoint Therapeutics$60M · Jan 2019

Quick answers about Leaps by Bayer

What does Leaps by Bayer invest in?

Leaps by Bayer invests most often at Series B and Series A (100% of the rounds on record), in sectors such as Agriculture, Agtech and Biotechnology.

How active is Leaps by Bayer?

8 investments on record, 2 of them in the last 12 months, and it led 2. The most recent was in Oct 2026.

What has Leaps by Bayer invested in recently?

Its most recent investments on record: Soufflé Therapeutics (Series B, Oct 2026), Robigo (Series A, Sept 2026) and Capstan Therapeutics (Series B, Mar 2024).

How big are Leaps by Bayer's cheques?

The median round it joins is $105M.

Does Leaps by Bayer lead rounds?

Yes: it led 2 of its 8 investments on record (25%).

Where does Leaps by Bayer invest?

Most of the companies it backs are in the United States (100%).

Is Leaps by Bayer investing now?

Yes: it is actively investing, with 2 investments in the last 12 months.

Who does Leaps by Bayer invest alongside?

Most often ARCH Venture Partners (2 rounds together), Alexandria Real Estate Equities (2 rounds together) and Polaris Partners (2 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it